Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

MASSACHUSETTS: Genocea Raises $30M to Advance Herpes Vaccine




 

Mass High Tech (Boston, MA) (10.10.12)

Genocea Biosciences Inc., a Cambridge, Mass.-based biotechnology company, has raised $30 million dollars in a Series C financing round, adding the Bill & Melinda Gates Foundation to its investor list. Genocea, a maker of vaccines, plans to use the funding to advance its potential therapeutic vaccine for herpes simplex virus type 2, currently undergoing a Phase 1/2a study. “We have made strong progress in our effort to create a new class of vaccines capable of combating serious infectious diseases that current vaccine discovery technologies cannot address,” stated Genocea CEO Chip Clark. “Completion of this financing round is a powerful vote of confidence from the financial community that will enable us to move aggressively to create new vaccines that will improve the health of patients around the world,” Clark added. In June 2012, he declared that the company planned to find a pharmaceutical company partner for the vaccine within the next year.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in October 11, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.